Ligand validation:3GGD

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3GGD_IMD_A_249	76%	53%	0.123	0.966	0.51	1.16	-	-	1	0	100%	1
2Y73_IMD_A_805	100%	60%	0.016	0.998	0.73	0.66	-	-	1	0	100%	1
2ASN_IMD_X_202	100%	62%	0.016	0.994	0.45	0.86	-	-	1	0	100%	1
1W8K_IMD_A_1476	100%	38%	0.02	0.995	1.16	1.17	-	-	0	0	100%	1
6G7X_IMD_E_302	100%	66%	0.021	0.995	0.69	0.47	-	-	0	0	100%	1
6THT_IMD_A_301	100%	70%	0.022	0.995	0.63	0.4	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.